Explained: Why WHO suspended hydroxychloroquine trials | Covid-19

Video Credit: HT Digital Content
Published on May 26, 2020 - Duration: 05:09s

Explained: Why WHO suspended hydroxychloroquine trials | Covid-19

The World Health Organization has temporarily halted trials on hydroxychloroquine due to safety concerns.

According to a study by The Lancet, patients given HCQ had higher death rates than those not on the drug.

WHO will review the data collected so far in Solidarity Trial and seven other studies globally.

WHO was investigating its use as a treatment for patients hospitalized with Covid-19, not as a drug to prevent the disease.

India is the world’s biggest producer of hydroxychloroquine.

Watch the full video for more details.

Advertisement

You are here

Related news from verified sources

[Premium Times] Barely 24 hours after the World Health Organisation (WHO) suspended all clinical trials for hydroxychloroquine as a potential treatment for...
on May 27, 2020 • allAfrica.com

Codebase Ventures Inc (CSE:CODE) (OTCQB:BKLLF), which owns a 49% stake in a company developing a transdermal hydroxychloroquine (HCQ) patch, told investors...
on May 11, 2020 • Proactive Investors

Related videos from verified sources

US Hospitals Cut Back On Use Of Hydroxychloroquine 00:32
Video credit: Wochit Entertainment - Published on May 31, 2020 

Watch: CSIR DG writes to WHO, says decision to halt HCQ trials is not correct 03:14
Video credit: HT Digital Content - Published on May 30, 2020 

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 01:29
Video credit: Cover Video STUDIO - Published on May 28, 2020 

You might like